# FGF23 Reduction : Efficacy of a New Phosphate Binder in CHronic Kidney Disease

> **NCT01220843** · PHASE3 · COMPLETED · sponsor: **Centre Hospitalier Universitaire, Amiens** · enrollment: 98 (actual)

## Conditions studied

- Chronic Renal Failure

## Interventions

- **DRUG:** Placebo
- **DRUG:** Sevelamer carbonate

## Key facts

- **NCT ID:** NCT01220843
- **Lead sponsor:** Centre Hospitalier Universitaire, Amiens
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-10
- **Primary completion:** 2013-04
- **Final completion:** 2013-04
- **Target enrollment:** 98 (ACTUAL)
- **Last updated:** 2025-09-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01220843

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01220843, "FGF23 Reduction : Efficacy of a New Phosphate Binder in CHronic Kidney Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01220843. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*